– PercayAI, launched by Kingdom Capital, represents the investment firm’s commitment to cultivating new technologies that can help accelerate drug discovery and improve patient outcomes
– Washington University School of Medicine in St. Louis will continue to develop technology that will be commercialized through PercayAI as part of an ongoing collaboration with Kingdom Capital
